Mr. Gaurav Mishra, Managing Associate at BananaIP Counsels delivered a talk on the Compulsory licensing provisions in India under the Patents Act on the 3rd...
Read more about Compulsory Licensing in India – Talk by Gaurav MishraTag: gilead
COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news
In this week’s Patent News – India asks G20 members to establish an agreement that enables the use of TRIPs flexibilities; EPO’s Enlarged Board of...
Read more about COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent newsAI cannot be an inventor rules USPTO, IPO extends SIPP Scheme and other patent news
In this week’s Patent News - Office of CGPDTM extends SIPP Scheme for a period of three years; CSIR allows firms to defer payments for...
Read more about AI cannot be an inventor rules USPTO, IPO extends SIPP Scheme and other patent newsApple faces multiple patent disputes, Brazil revokes Gilead’s drug patent, Interesting Inventions and more
This update highlights major patent disputes involving Apple and the revocation of Gilead’s drug patent in Brazil. It also offers detailed patent statistics, notable inventions, and insights into global and Indian intellectual property trends.
Read more about Apple faces multiple patent disputes, Brazil revokes Gilead’s drug patent, Interesting Inventions and moreGilead, IPA, Natco & The Bells of Harmony
The post examines the collaboration between Gilead, IPA, and Natco Pharma regarding the sofosbuvir patent in India. It analyses how voluntary licensing and innovative policies are improving access to affordable medicines while balancing public health and patent rights.
Read more about Gilead, IPA, Natco & The Bells of Harmony